Vennegoor C J, van de Wiel-van Kemenade E, Huijbens R J, Sanchez-Madrid F, Melief C J, Figdor C G
Division of Immunology, The Netherlands Cancer Institute, Antoni van Leeuwenhoekhuis, Amsterdam.
J Immunol. 1992 Feb 15;148(4):1093-101.
Patients with the leukocyte adhesion deficiency (LAD) syndrome have a genetic defect in the common beta 2-chain (CD18) of the leukocyte integrins. This defect can result in the absence of cell surface expression of all three members of the leukocyte integrins. We investigated the capacity of T cell clones obtained from the blood of an LAD patient and of normal T cell clones to adhere to human umbilical vein endothelial cells (EC). Adhesion of the number of LAD T cells to unstimulated EC was approximately half of that of leukocyte function-associated antigen (LFA)-1+ T cells. Stimulation of EC with human rTNF-alpha resulted in an average 2- and 2.5-fold increase in adhesion of LFA-1+ and LFA-1- cells, respectively. This effect was maximal after 24 h and lasted for 48 to 72 h. The involvement of surface structures known to participate in cell adhesion (integrins, CD44) was tested by blocking studies with mAb directed against these structures. Adhesion of LFA-1+ T cells to unstimulated EC was inhibited (average inhibition of 58%) with mAb to CD11a or CD18. Considerably less inhibition of adhesion occurred with mAb to CD11a or CD18 (average inhibition, 20%) when LFA-1+ T cells were incubated with rTNF-alpha-stimulated EC. The adhesion of LFA-1- T cells to EC stimulated with rTNF-alpha, but not to unstimulated EC, was inhibited (average inhibition, 56%) by incubation with a mAb directed to very late antigen (VLA)-4 (CDw49d). In contrast to LAD T cell clones and the LFA-1+ T cell line Jurkat, mAb to VLA-4 did not inhibit adhesion of normal LFA-1+ T cell clones to EC, whether or not the EC had been stimulated with rTNF-alpha. We conclude that the adhesion molecule pair LFA-1/intercellular adhesion molecule (ICAM)-1 plays a major role in the adhesion of LFA-1+ T cell clones derived from normal individuals to unstimulated EC. Adhesion of LFA-1-T cells to TNF-alpha-stimulated EC is mediated by VLA-4/vascular cell adhesion molecule (VCAM)-1 interactions. Since we were unable to reduce significantly the adhesion of cultured normal LFA-1+ T cells to 24 h with TNF-alpha-stimulated endothelium with antibodies that block LFA-1/ICAM-1 or VLA-4/VCAM-1 interactions, and lectin adhesion molecule-1 and endothelial leukocyte adhesion molecule-1 appeared not to be implicated, other as yet undefined cell surface structures are likely to participate in T cell/EC interactions.
白细胞黏附缺陷(LAD)综合征患者在白细胞整合素的共同β2链(CD18)上存在基因缺陷。这种缺陷可导致白细胞整合素的所有三个成员在细胞表面均无表达。我们研究了从一名LAD患者血液中获得的T细胞克隆以及正常T细胞克隆与人类脐静脉内皮细胞(EC)黏附的能力。LAD T细胞与未刺激的EC的黏附数量约为白细胞功能相关抗原(LFA)-1⁺ T细胞的一半。用人重组肿瘤坏死因子-α(rTNF-α)刺激EC后,LFA-1⁺和LFA-1⁻细胞的黏附分别平均增加了2倍和2.5倍。这种效应在24小时后达到最大,并持续48至72小时。通过用针对这些结构的单克隆抗体进行阻断研究,测试了已知参与细胞黏附的表面结构(整合素、CD44)的作用。用抗CD11a或CD18的单克隆抗体可抑制LFA-1⁺ T细胞与未刺激的EC的黏附(平均抑制率为58%)。当LFA-1⁺ T细胞与rTNF-α刺激的EC孵育时,用抗CD11a或CD18的单克隆抗体对黏附的抑制作用明显减弱(平均抑制率为20%)。用针对极晚期抗原(VLA)-4(CDw49d)的单克隆抗体孵育可抑制LFA-1⁻ T细胞与rTNF-α刺激的EC的黏附,但不抑制与未刺激的EC的黏附(平均抑制率为56%)。与LAD T细胞克隆和LFA-1⁺ T细胞系Jurkat不同,抗VLA-4的单克隆抗体不抑制正常LFA-1⁺ T细胞克隆与EC的黏附,无论EC是否用rTNF-α刺激。我们得出结论,黏附分子对LFA-1/细胞间黏附分子(ICAM)-1在源自正常个体的LFA-1⁺ T细胞克隆与未刺激的EC的黏附中起主要作用。LFA-1⁻ T细胞与TNF-α刺激的EC的黏附是由VLA-4/血管细胞黏附分子(VCAM)-1相互作用介导的。由于我们无法用阻断LFA-1/ICAM-1或VLA-4/VCAM-1相互作用的抗体显著降低培养的正常LFA-1⁺ T细胞与24小时用TNF-α刺激的内皮细胞的黏附,且凝集素黏附分子-1和内皮白细胞黏附分子-1似乎未参与其中,其他尚未明确的细胞表面结构可能参与了T细胞/EC相互作用。